Questions linger over first lady's visa status
The Washington Post reports Melania Trump secured U S residency in 2001 under the EB-1 extraordinary ability category. Experts question how her credentials and achievements met the stringent criteria and note the broader debate on chain migration and relatives' sponsorships.
MENTIONED IN THIS ARTICLE
Washington
Melania Knauss
Donald Trump
United States
Bruce Morrison
House
Knauss
Melania Trump
Slovenia
State Department
U.S
Viktor
Amaliya Knaus
Washington Post
Trump
Michael Wildes
Wildes
White House
Morrison
David Leopold
American Immigration Lawyers Association
Sarah Pierce
Migration Policy Institute
New York
Page Six
Anxiety over immigration grips young children in multiple states
A CLASP study of over 100 early care workers in six states finds children under eight fear parental deportation and withdraw from activities. Many undocumented parents limit healthcare and education access for citizen children, with widespread anxiety and depressive symptoms noted by educators and advocates.
MENTIONED IN THIS ARTICLE
Philadelphia
Pennsylvania
Trump
Mexico
United States
America
U.S
Center For Law and Social Policy
Washington
California
Georgia
Illinois
New Mexico
North Carolina
Hannah Matthews
U.S. Citizens
Matthews
CLASP
Donna Cooper
Public Citizens For Children and Youth
Philippe Weisz
Hias Pennsylvania
Weisz
Maryland
Alexandra Wolkoff
Puentes de Salud
Volkoff
Philip Kendall
Temple University
Mary Graham
Children’s Village
Center City
Conservative Heritage Foundation
Memroy boosting pill Navix touted as age related memory fix
A health press feature promotes Navix a memory pill claiming fast reversal of age related memory loss. It cites studies investors and doctors including Dr Peter Grossman and L P Barnes and offers a 48 hour discount via toll free 1 800 983 1073 with code NX247 while noting FDA evaluation not completed.
MENTIONED IN THIS ARTICLE
Dr. Oz
Peter Grossman
Philadelphia
Also Mentioned on This Page
Mary Jordan
The
Daniel Ward Sr
Associated Health Press
Nuvix
L.P. Barnes
Nolan Laboratories
Food and Drug Administration